期刊文献+

彩色多普勒超声对小儿神经母细胞瘤的诊断价值 预览

在线阅读 下载PDF
分享 导出
摘要 神经母细胞瘤(neuroblastoma,NB)是起源于交感神经元系统或肾上腺髓质的恶性肿瘤,小儿发病率高,年发病率为0.3/10万~5.5/10万[1]。NB以腹膜后多见,起病隐匿,恶性程度高,早期即可发生远处转移[2],及时准确的诊断对患儿术前评估和术后随访有重要的临床意义。超声检查可动态观察肿块内部结构、血供及与周围脏器的毗邻关系,是儿童神经母细胞瘤首选的检查方法。本文通过对24例NB患儿的超声图像进行回顾性分析,现报道如下。
出处 《实用医学影像杂志》 2019年第1期76-77,共2页 Journal of Practical Medical Imaging
  • 相关文献

参考文献3

二级参考文献40

  • 1李新华,杨有优,余雷,姜国华,黄泽中.CT在儿童神经母细胞瘤诊断和随访中的价值[J].基层医学论坛,2007,11(9):807-809. 被引量:4
  • 2Briganti V, Sestini R, Orland C, et al. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors [J]. Clin Cancer Res, 1997, 3: 2385-2391. 被引量:1
  • 3Yeh SDJ, Larson SM, Butch L, et al. Radioimmunodetection of neuroblastoma with iodine-131-3F8: Correlation with biopsy, iodine-131-metaiodobenzylgnanidine and standard diagnostic modalities[J]. J Nucl Med, 1991, 32(5): 769-776. 被引量:1
  • 4Leung A, Shapiro B, Hattner R, et al. Specificity of radioiodinated MIBG for neural crest tumors in childhood [J]. J Nucl Med, 1997, 38(9): 1352-1357. 被引量:1
  • 5Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumors [J]. Eur J Nucl Med, 1994, 21(6): 561-581. 被引量:1
  • 6Brans B, Laureys G, Scheffhout V, et al. Activity of iodine-123 metaiodobenzylguanidine in childhood neuroblastoma: lack of relation to tumor differentiation in vivo [J]. Eur J Nucl Med, 1998, 25(2): 144-149. 被引量:1
  • 7Kropp J, Hofmann M, Bihl H. Comparison of MIBG and pentetreotide scintigraphy in children with neuroblastoma.: Is the expression of somatostatin receptors a prognostic factor? [J]. Anticancer Res, 1997, 17: 1583-1588. 被引量:1
  • 8Hoefnagel CA, Rutgers M, Buitcnhnis CKM, et al. A comparison of targeting of neuroblastoma with MIBG and anti L1-CAM antibody mAb ehCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblasroma patients[J]. Eur J Nucl Med, 2001, 28(3): 359-368. 被引量:1
  • 9Shulkin BL, Hutchinson RJ, Castle VP, et al. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylg uanidine scintigraphy[J]. Radiology, 1996,199(3): 743-750. 被引量:1
  • 10Kushner BH, Yeung HWD, Larson SM, et al. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients[J]. J Clin Oncol, 2001, 19(14): 3397-3405. 被引量:1

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈